

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Golgi transport vesicle coating (GO:0048200) | 4.52123125 |
| 2 | COPI coating of Golgi vesicle (GO:0048205) | 4.52123125 |
| 3 | signal peptide processing (GO:0006465) | 3.96064110 |
| 4 | ER overload response (GO:0006983) | 3.44383161 |
| 5 | fatty acid elongation (GO:0030497) | 3.38267685 |
| 6 | mitochondrial electron transport, NADH to ubiquinone (GO:0006120) | 3.33017472 |
| 7 | axon ensheathment in central nervous system (GO:0032291) | 3.20945379 |
| 8 | central nervous system myelination (GO:0022010) | 3.20945379 |
| 9 | protein maturation by protein folding (GO:0022417) | 3.16626979 |
| 10 | xenobiotic catabolic process (GO:0042178) | 3.16307063 |
| 11 | peptide hormone processing (GO:0016486) | 3.16286054 |
| 12 | COPII vesicle coating (GO:0048208) | 3.15247086 |
| 13 | regulation of integrin-mediated signaling pathway (GO:2001044) | 3.14846531 |
| 14 | nucleotide transmembrane transport (GO:1901679) | 3.08233434 |
| 15 | regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway (GO:1902235 | 3.03290436 |
| 16 | regulation of podosome assembly (GO:0071801) | 3.02107668 |
| 17 | autophagic vacuole fusion (GO:0000046) | 3.00316098 |
| 18 | toxin metabolic process (GO:0009404) | 3.00291074 |
| 19 | retrograde vesicle-mediated transport, Golgi to ER (GO:0006890) | 2.97903278 |
| 20 | detection of calcium ion (GO:0005513) | 2.91347855 |
| 21 | endocrine pancreas development (GO:0031018) | 2.85780698 |
| 22 | maintenance of protein localization in endoplasmic reticulum (GO:0035437) | 2.83718515 |
| 23 | ketone body metabolic process (GO:1902224) | 2.83218909 |
| 24 | neutrophil activation involved in immune response (GO:0002283) | 2.82419736 |
| 25 | beta-amyloid metabolic process (GO:0050435) | 2.81956774 |
| 26 | negative regulation of interleukin-17 production (GO:0032700) | 2.77403351 |
| 27 | nucleoside diphosphate catabolic process (GO:0009134) | 2.76304923 |
| 28 | respiratory electron transport chain (GO:0022904) | 2.72891353 |
| 29 | regulation of type B pancreatic cell apoptotic process (GO:2000674) | 2.72063488 |
| 30 | electron transport chain (GO:0022900) | 2.71136395 |
| 31 | positive regulation of receptor recycling (GO:0001921) | 2.70074305 |
| 32 | cholesterol biosynthetic process (GO:0006695) | 2.69103155 |
| 33 | mitochondrial ATP synthesis coupled proton transport (GO:0042776) | 2.68068652 |
| 34 | energy coupled proton transport, down electrochemical gradient (GO:0015985) | 2.62933354 |
| 35 | ATP synthesis coupled proton transport (GO:0015986) | 2.62933354 |
| 36 | organelle membrane fusion (GO:0090174) | 2.61159443 |
| 37 | protein retention in ER lumen (GO:0006621) | 2.61077281 |
| 38 | negative regulation of ryanodine-sensitive calcium-release channel activity (GO:0060315) | 2.60914468 |
| 39 | long-chain fatty-acyl-CoA biosynthetic process (GO:0035338) | 2.58541236 |
| 40 | response to redox state (GO:0051775) | 2.56851626 |
| 41 | L-phenylalanine catabolic process (GO:0006559) | 2.56850160 |
| 42 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process (GO:1902222) | 2.56850160 |
| 43 | positive regulation of chemokine biosynthetic process (GO:0045080) | 2.55696257 |
| 44 | regulation of autophagic vacuole assembly (GO:2000785) | 2.55693644 |
| 45 | substantia nigra development (GO:0021762) | 2.53606412 |
| 46 | eye photoreceptor cell differentiation (GO:0001754) | 2.53160603 |
| 47 | photoreceptor cell differentiation (GO:0046530) | 2.53160603 |
| 48 | regulation of receptor recycling (GO:0001919) | 2.52094054 |
| 49 | thrombin receptor signaling pathway (GO:0070493) | 2.48149852 |
| 50 | fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540) | 2.47997437 |
| 51 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 2.46617425 |
| 52 | response to gravity (GO:0009629) | 2.44264808 |
| 53 | dopamine biosynthetic process (GO:0042416) | 2.43583727 |
| 54 | insulin secretion (GO:0030073) | 2.41819792 |
| 55 | ATP hydrolysis coupled proton transport (GO:0015991) | 2.41545022 |
| 56 | energy coupled proton transmembrane transport, against electrochemical gradient (GO:0015988) | 2.41545022 |
| 57 | sterol biosynthetic process (GO:0016126) | 2.41083635 |
| 58 | ER-associated ubiquitin-dependent protein catabolic process (GO:0030433) | 2.40748492 |
| 59 | creatine metabolic process (GO:0006600) | 2.40177141 |
| 60 | fatty-acyl-CoA biosynthetic process (GO:0046949) | 2.39764828 |
| 61 | angiogenesis involved in wound healing (GO:0060055) | 2.37863000 |
| 62 | thioester biosynthetic process (GO:0035384) | 2.37401930 |
| 63 | acyl-CoA biosynthetic process (GO:0071616) | 2.37401930 |
| 64 | positive regulation of macrophage derived foam cell differentiation (GO:0010744) | 2.37388277 |
| 65 | regulation of ER to Golgi vesicle-mediated transport (GO:0060628) | 2.35996779 |
| 66 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 2.35506998 |
| 67 | sequestering of metal ion (GO:0051238) | 2.35203870 |
| 68 | ER to Golgi vesicle-mediated transport (GO:0006888) | 2.34941741 |
| 69 | GDP-mannose metabolic process (GO:0019673) | 2.34774161 |
| 70 | fatty-acyl-CoA metabolic process (GO:0035337) | 2.33917217 |
| 71 | long-chain fatty-acyl-CoA metabolic process (GO:0035336) | 2.33688592 |
| 72 | calcium-mediated signaling using intracellular calcium source (GO:0035584) | 2.33170387 |
| 73 | regulation of cilium movement (GO:0003352) | 2.33093335 |
| 74 | magnesium ion transport (GO:0015693) | 2.32279346 |
| 75 | regulation of cholesterol esterification (GO:0010872) | 2.31924474 |
| 76 | peroxisome fission (GO:0016559) | 2.31435202 |
| 77 | phenol-containing compound catabolic process (GO:0019336) | 2.30381387 |
| 78 | negative regulation of JUN kinase activity (GO:0043508) | 2.29703061 |
| 79 | negative regulation of neurological system process (GO:0031645) | 2.29505861 |
| 80 | positive regulation of insulin secretion (GO:0032024) | 2.29406869 |
| 81 | intra-Golgi vesicle-mediated transport (GO:0006891) | 2.27842141 |
| 82 | negative regulation of neurotransmitter secretion (GO:0046929) | 2.27794604 |
| 83 | glandular epithelial cell differentiation (GO:0002067) | 2.26711743 |
| 84 | regulation of regulatory T cell differentiation (GO:0045589) | 2.26541047 |
| 85 | regulation of amyloid precursor protein catabolic process (GO:1902991) | 2.26036893 |
| 86 | L-phenylalanine metabolic process (GO:0006558) | 2.23562680 |
| 87 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process (GO:1902221) | 2.23562680 |
| 88 | antigen processing and presentation of endogenous antigen (GO:0019883) | 2.23496006 |
| 89 | regulation of oxidative phosphorylation (GO:0002082) | 2.22362826 |
| 90 | positive regulation of mitochondrial calcium ion concentration (GO:0051561) | 2.22213503 |
| 91 | endosome to pigment granule transport (GO:0043485) | 2.22203819 |
| 92 | endosome to melanosome transport (GO:0035646) | 2.22203819 |
| 93 | transferrin transport (GO:0033572) | 2.22038492 |
| 94 | regulation of insulin secretion (GO:0050796) | 2.21897232 |
| 95 | response to dietary excess (GO:0002021) | 2.21707931 |
| 96 | macroautophagy (GO:0016236) | 2.21654513 |
| 97 | regulation of chemokine biosynthetic process (GO:0045073) | 2.20220334 |
| 98 | peptide catabolic process (GO:0043171) | 2.20152283 |
| 99 | regulation of extracellular matrix disassembly (GO:0010715) | 2.20106366 |
| 100 | regulation of mesenchymal to epithelial transition involved in metanephros morphogenesis (GO:0003339 | 2.19624751 |
| 101 | negative regulation of neurotransmitter transport (GO:0051589) | 2.19211780 |
| 102 | cellular response to glucagon stimulus (GO:0071377) | 2.19043581 |
| 103 | positive regulation of insulin secretion involved in cellular response to glucose stimulus (GO:00357 | 2.18986922 |
| 104 | trivalent inorganic cation transport (GO:0072512) | 2.18397336 |
| 105 | ferric iron transport (GO:0015682) | 2.18397336 |
| 106 | peptidyl-tyrosine autophosphorylation (GO:0038083) | 2.17890540 |
| 107 | phagosome maturation (GO:0090382) | 2.17047843 |
| 108 | tonic smooth muscle contraction (GO:0014820) | 2.14649023 |
| 109 | positive regulation of isotype switching (GO:0045830) | 2.14178093 |
| 110 | regulation of vacuole organization (GO:0044088) | 2.14003624 |
| 111 | mitochondrial calcium ion transport (GO:0006851) | 2.13621082 |
| 112 | positive regulation of steroid metabolic process (GO:0045940) | 2.13532382 |
| 113 | extracellular fibril organization (GO:0043206) | 2.13223951 |
| 114 | protein complex biogenesis (GO:0070271) | 2.13202368 |
| 115 | fucose metabolic process (GO:0006004) | 2.13076277 |
| 116 | positive regulation of action potential (GO:0045760) | 2.12592338 |
| 117 | protein localization to Golgi apparatus (GO:0034067) | 2.12455067 |
| 118 | vesicle coating (GO:0006901) | 2.11928909 |
| 119 | negative regulation of calcium ion transmembrane transport (GO:1903170) | 2.11812550 |
| 120 | negative regulation of calcium ion transmembrane transporter activity (GO:1901020) | 2.11812550 |
| 121 | regulation of glucocorticoid secretion (GO:2000849) | 2.11630369 |
| 122 | amyloid precursor protein catabolic process (GO:0042987) | 2.11116364 |
| 123 | 3-phosphoadenosine 5-phosphosulfate metabolic process (GO:0050427) | 2.11099999 |
| 124 | purine ribonucleoside bisphosphate metabolic process (GO:0034035) | 2.11099999 |
| 125 | positive regulation of DNA recombination (GO:0045911) | 2.10679981 |
| 126 | regulation of macrophage derived foam cell differentiation (GO:0010743) | 2.10031885 |
| 127 | protein neddylation (GO:0045116) | 2.10030206 |
| 128 | regulation of synaptic vesicle exocytosis (GO:2000300) | 2.09242126 |
| 129 | negative regulation of inflammatory response to antigenic stimulus (GO:0002862) | 2.08572554 |
| 130 | mitochondrial calcium ion homeostasis (GO:0051560) | 2.08295435 |
| 131 | peptide metabolic process (GO:0006518) | 2.07263101 |
| 132 | myelination (GO:0042552) | 2.06869028 |
| 133 | positive regulation of calcium ion-dependent exocytosis (GO:0045956) | 2.06842221 |
| 134 | plasma membrane fusion (GO:0045026) | 2.06753413 |
| 135 | calcium ion-dependent exocytosis (GO:0017156) | 2.06749574 |
| 136 | response to methylmercury (GO:0051597) | 2.06601923 |
| 137 | regulation of interleukin-6 biosynthetic process (GO:0045408) | 2.05288044 |
| 138 | axon ensheathment (GO:0008366) | 2.05191039 |
| 139 | ensheathment of neurons (GO:0007272) | 2.05191039 |
| 140 | hydrogen ion transmembrane transport (GO:1902600) | 2.04842945 |
| 141 | long-chain fatty acid biosynthetic process (GO:0042759) | 2.04742681 |
| 142 | very long-chain fatty acid metabolic process (GO:0000038) | 2.03840566 |
| 143 | aldehyde catabolic process (GO:0046185) | 2.03745311 |
| 144 | mannosylation (GO:0097502) | 2.03560840 |
| 145 | negative regulation of humoral immune response (GO:0002921) | 2.03510005 |
| 146 | regulation of peptide hormone secretion (GO:0090276) | 2.03118943 |
| 147 | cellular ketone body metabolic process (GO:0046950) | 2.02855447 |
| 148 | amyloid precursor protein metabolic process (GO:0042982) | 2.02665917 |
| 149 | regulation of catecholamine metabolic process (GO:0042069) | 2.01948797 |
| 150 | regulation of dopamine metabolic process (GO:0042053) | 2.01948797 |
| 151 | regulation of metalloenzyme activity (GO:0048552) | 1.99856882 |
| 152 | regulation of platelet aggregation (GO:0090330) | 1.98767964 |
| 153 | negative regulation of glycoprotein biosynthetic process (GO:0010561) | 1.98344540 |
| 154 | blood coagulation, intrinsic pathway (GO:0007597) | 1.98083681 |
| 155 | lipoxygenase pathway (GO:0019372) | 1.97679207 |
| 156 | regulation of MHC class II biosynthetic process (GO:0045346) | 1.97532906 |
| 157 | glycerophospholipid catabolic process (GO:0046475) | 1.97415091 |
| 158 | L-ascorbic acid metabolic process (GO:0019852) | 1.97049423 |
| 159 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 1.96831133 |
| 160 | negative regulation of cell killing (GO:0031342) | 1.96831133 |
| 161 | regulation of lipoprotein metabolic process (GO:0050746) | 1.96543763 |
| 162 | negative regulation of endoplasmic reticulum calcium ion concentration (GO:0032471) | 1.96459261 |
| 163 | fibril organization (GO:0097435) | 1.96306171 |
| 164 | negative regulation of glycoprotein metabolic process (GO:1903019) | 1.95811735 |
| 165 | positive regulation of granulocyte differentiation (GO:0030854) | 1.95611939 |
| 166 | artery smooth muscle contraction (GO:0014824) | 1.95452980 |
| 167 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 1.95124638 |
| 168 | positive regulation of steroid biosynthetic process (GO:0010893) | 1.94822974 |
| 169 | negative regulation of nitric oxide biosynthetic process (GO:0045019) | 1.94427246 |
| 170 | cellular response to leptin stimulus (GO:0044320) | 1.94127352 |
| 171 | low-density lipoprotein particle remodeling (GO:0034374) | 1.93543929 |
| 172 | platelet aggregation (GO:0070527) | 1.92753495 |
| 173 | endoplasmic reticulum calcium ion homeostasis (GO:0032469) | 1.92358237 |
| 174 | monoamine transport (GO:0015844) | 1.92212975 |
| 175 | positive regulation of tyrosine phosphorylation of Stat1 protein (GO:0042511) | 1.91716642 |
| 176 | branched-chain amino acid catabolic process (GO:0009083) | 1.91190340 |
| 177 | negative regulation of protein localization to plasma membrane (GO:1903077) | 1.90220908 |
| 178 | regulation of memory T cell differentiation (GO:0043380) | 1.89720122 |
| 179 | response to interferon-beta (GO:0035456) | 1.89339490 |
| 180 | inositol phosphate catabolic process (GO:0071545) | 1.88979925 |
| 181 | positive regulation of actin filament depolymerization (GO:0030836) | 1.88876461 |
| 182 | phosphorylated carbohydrate dephosphorylation (GO:0046838) | 1.88053350 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 3.73947761 |
| 2 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 2.74362140 |
| 3 | GBX2_23144817_ChIP-Seq_PC3_Human | 2.73459634 |
| 4 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 2.60203575 |
| 5 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 2.59412941 |
| 6 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 2.44207273 |
| 7 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 2.28390503 |
| 8 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 2.15424066 |
| 9 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 2.14946465 |
| 10 | EZH2_22144423_ChIP-Seq_EOC_Human | 2.13227447 |
| 11 | VDR_22108803_ChIP-Seq_LS180_Human | 2.11434517 |
| 12 | SUZ12_18692474_ChIP-Seq_MESCs_Mouse | 1.97332819 |
| 13 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 1.96230856 |
| 14 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 1.93241007 |
| 15 | SUZ12_20075857_ChIP-Seq_MESCs_Mouse | 1.91162170 |
| 16 | PDX1_19855005_ChIP-ChIP_MIN6_Mouse | 1.88794439 |
| 17 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 1.85762291 |
| 18 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 1.85578493 |
| 19 | SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 1.84682106 |
| 20 | SUZ12_18692474_ChIP-Seq_MEFs_Mouse | 1.81516152 |
| 21 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.73789987 |
| 22 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 1.73177226 |
| 23 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.72918819 |
| 24 | MTF2_20144788_ChIP-Seq_MESCs_Mouse | 1.72620809 |
| 25 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 1.68934392 |
| 26 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 1.68457353 |
| 27 | NR3C1_23031785_ChIP-Seq_PC12_Mouse | 1.67492454 |
| 28 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.62992372 |
| 29 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 1.62788260 |
| 30 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 1.61852573 |
| 31 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.60905680 |
| 32 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 1.60316711 |
| 33 | TAF15_26573619_Chip-Seq_HEK293_Human | 1.57755334 |
| 34 | JARID2_20075857_ChIP-Seq_MESCs_Mouse | 1.56464277 |
| 35 | STAT1_20625510_ChIP-Seq_HELA_Human | 1.56276091 |
| 36 | SUZ12_18974828_ChIP-Seq_MESCs_Mouse | 1.55310652 |
| 37 | NOTCH1_17114293_ChIP-ChIP_T-ALL_Human | 1.54659593 |
| 38 | EZH2_27304074_Chip-Seq_ESCs_Mouse | 1.54403066 |
| 39 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.53867821 |
| 40 | EZH2_27294783_Chip-Seq_ESCs_Mouse | 1.53170190 |
| 41 | SMARCA4_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.53108831 |
| 42 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 1.52455016 |
| 43 | EED_16625203_ChIP-ChIP_MESCs_Mouse | 1.51575620 |
| 44 | SUZ12_16625203_ChIP-ChIP_MESCs_Mouse | 1.51078960 |
| 45 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 1.50882174 |
| 46 | REST_21632747_ChIP-Seq_MESCs_Mouse | 1.49064920 |
| 47 | SUZ12_27294783_Chip-Seq_ESCs_Mouse | 1.46235744 |
| 48 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 1.45753392 |
| 49 | GATA1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.43996507 |
| 50 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 1.43731620 |
| 51 | EP300_21415370_ChIP-Seq_HL-1_Mouse | 1.42835891 |
| 52 | GATA1_19941826_ChIP-Seq_K562_Human | 1.40396324 |
| 53 | JARID2_20064375_ChIP-Seq_MESCs_Mouse | 1.40242331 |
| 54 | ZFP57_27257070_Chip-Seq_ESCs_Mouse | 1.40215134 |
| 55 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.38614139 |
| 56 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.38161976 |
| 57 | SPI1_23127762_ChIP-Seq_K562_Human | 1.37952068 |
| 58 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 1.37538989 |
| 59 | POU3F2_20337985_ChIP-ChIP_501MEL_Human | 1.36553535 |
| 60 | BMI1_23680149_ChIP-Seq_NPCS_Mouse | 1.36107997 |
| 61 | OLIG2_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.34827054 |
| 62 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 1.33001269 |
| 63 | GATA1_22025678_ChIP-Seq_K562_Human | 1.32737186 |
| 64 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 1.31196346 |
| 65 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 1.30953996 |
| 66 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 1.30953996 |
| 67 | CTBP2_25329375_ChIP-Seq_LNCAP_Human | 1.29758218 |
| 68 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 1.29685860 |
| 69 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 1.29449278 |
| 70 | RNF2_18974828_ChIP-Seq_MESCs_Mouse | 1.28699718 |
| 71 | EZH2_18974828_ChIP-Seq_MESCs_Mouse | 1.28699718 |
| 72 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.28301580 |
| 73 | REST_18959480_ChIP-ChIP_MESCs_Mouse | 1.28140883 |
| 74 | SCL_19346495_ChIP-Seq_HPC-7_Human | 1.26895808 |
| 75 | * ELF1_20517297_ChIP-Seq_JURKAT_Human | 1.26811519 |
| 76 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.26123497 |
| 77 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 1.25080222 |
| 78 | DROSHA_22980978_ChIP-Seq_HELA_Human | 1.21960580 |
| 79 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 1.20702190 |
| 80 | PAX3-FKHR_20663909_ChIP-Seq_RHABDOMYOSARCOMA_Human | 1.20447105 |
| 81 | ATF3_23680149_ChIP-Seq_GBM1-GSC_Human | 1.20175993 |
| 82 | DMRT1_21621532_ChIP-ChIP_FETAL_Ovary | 1.19674014 |
| 83 | CTBP1_25329375_ChIP-Seq_LNCAP_Human | 1.19069382 |
| 84 | SRF_21415370_ChIP-Seq_HL-1_Mouse | 1.18371016 |
| 85 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 1.17458123 |
| 86 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.17153252 |
| 87 | TOP2B_26459242_ChIP-Seq_MCF-7_Human | 1.16896966 |
| 88 | BCOR_27268052_Chip-Seq_Bcells_Human | 1.16614736 |
| 89 | SMAD4_21799915_ChIP-Seq_A2780_Human | 1.12966383 |
| 90 | BCL6_27268052_Chip-Seq_Bcells_Human | 1.12820522 |
| 91 | GATA2_19941826_ChIP-Seq_K562_Human | 1.11480343 |
| 92 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 1.08781870 |
| 93 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 1.08183866 |
| 94 | PBX_27287812_Chip-Seq_EMBYONIC-LIMB_Mouse | 1.06499632 |
| 95 | WT1_19549856_ChIP-ChIP_CCG9911_Human | 1.06239685 |
| 96 | P300_19829295_ChIP-Seq_ESCs_Human | 1.06118449 |
| 97 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.06061313 |
| 98 | SPI1_23547873_ChIP-Seq_NB4_Human | 1.04806961 |
| 99 | RUNX_20019798_ChIP-Seq_JUKART_Human | 1.03788836 |
| 100 | RAD21_21589869_ChIP-Seq_MESCs_Mouse | 1.03614270 |
| 101 | JUND_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.02530661 |
| 102 | RNF2_27304074_Chip-Seq_ESCs_Mouse | 1.02449798 |
| 103 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.02369268 |
| 104 | JUN_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.01819902 |
| 105 | P300_27268052_Chip-Seq_Bcells_Human | 1.01586561 |
| 106 | PPARG_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.01350357 |
| 107 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 0.99844966 |
| 108 | CEBPB_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.99689308 |
| 109 | NR4A2_19515692_ChIP-ChIP_MN9D_Mouse | 0.99041480 |
| 110 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 0.98631775 |
| 111 | PBX1_22567123_ChIP-ChIP_OVCAR3_Human | 0.98466382 |
| 112 | ER_23166858_ChIP-Seq_MCF-7_Human | 0.98233232 |
| 113 | PU.1_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.98193804 |
| 114 | MEIS1_26253404_ChIP-Seq_OPTIC_CUPS_Mouse | 0.98086407 |
| 115 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.97918657 |
| 116 | SMAD2/3_21741376_ChIP-Seq_EPCs_Human | 0.97382973 |
| 117 | ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 0.97220438 |
| 118 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 0.96146851 |
| 119 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 0.95361726 |
| 120 | HTT_18923047_ChIP-ChIP_STHdh_Human | 0.94783272 |
| 121 | VDR_24763502_ChIP-Seq_THP-1_Human | 0.94756969 |
| 122 | ZNF274_21170338_ChIP-Seq_K562_Hela | 0.94618226 |
| 123 | SPI1_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.94450870 |
| 124 | LXR_22292898_ChIP-Seq_THP-1_Human | 0.93730866 |
| 125 | AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 0.93684856 |
| 126 | TAL1_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.93366345 |
| 127 | OLIG2_26023283_ChIP-Seq_AINV15_Mouse | 0.93077211 |
| 128 | ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 0.92779571 |
| 129 | PHC1_16625203_ChIP-ChIP_MESCs_Mouse | 0.92376649 |
| 130 | EWS-FLI1_20517297_ChIP-Seq_SK-N-MC_Human | 0.91886667 |
| 131 | FLI1_21867929_ChIP-Seq_TH2_Mouse | 0.91853568 |
| 132 | SOX2_21211035_ChIP-Seq_LN229_Gbm | 0.91197484 |
| 133 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 0.91185321 |
| 134 | * SOX2_20726797_ChIP-Seq_SW620_Human | 0.91100141 |
| 135 | SOX2_19829295_ChIP-Seq_ESCs_Human | 0.90721436 |
| 136 | NANOG_19829295_ChIP-Seq_ESCs_Human | 0.90721436 |
| 137 | RCOR1_19997604_ChIP-ChIP_NEURONS_Mouse | 0.90097383 |
| 138 | ETV2_25802403_ChIP-Seq_MESCs_Mouse | 0.90074479 |
| 139 | CTCF_20526341_ChIP-Seq_ESCs_Human | 0.89723605 |
| 140 | SMAD3_21741376_ChIP-Seq_EPCs_Human | 0.89625394 |
| 141 | FOXA1_21915096_ChIP-Seq_LNCaP-1F5_Human | 0.89512041 |
| 142 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 0.89219112 |
| 143 | AR_20517297_ChIP-Seq_VCAP_Human | 0.89089942 |
| 144 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 0.88810566 |
| 145 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 0.88686879 |
| 146 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 0.87890905 |
| 147 | UBF1/2_26484160_Chip-Seq_FIBROBLAST_Human | 0.87886350 |
| 148 | REST_19997604_ChIP-ChIP_NEURONS_Mouse | 0.87808401 |
| 149 | CBX2_27304074_Chip-Seq_ESCs_Mouse | 0.87537083 |
| 150 | SPI1_20517297_ChIP-Seq_HL60_Human | 0.87520051 |
| 151 | * CRX_20693478_ChIP-Seq_ADULT_RETINA_Mouse | 0.87509074 |
| 152 | STAT3_23295773_ChIP-Seq_U87_Human | 0.86900438 |
| 153 | BCAT_22108803_ChIP-Seq_LS180_Human | 0.85939374 |
| 154 | SOX9_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 0.84292403 |
| 155 | GRHL2_25758223_ChIP-Seq_PLACENTA_Mouse | 0.83978018 |
| 156 | TAL1_26923725_Chip-Seq_HPCs_Mouse | 0.83965321 |
| 157 | KDM2B_26808549_Chip-Seq_REH_Human | 0.83959453 |
| 158 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 0.83880348 |
| 159 | SPI1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 0.83274109 |
| 160 | AR_21572438_ChIP-Seq_LNCaP_Human | 0.83207414 |
| 161 | PU.1_20513432_ChIP-Seq_Bcells_Mouse | 0.82679767 |
| 162 | LMO2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.82613135 |
| 163 | ZNF217_24962896_ChIP-Seq_MCF-7_Human | 0.82424572 |
| 164 | GATA3_26560356_Chip-Seq_TH2_Human | 0.82299932 |
| 165 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 0.82081268 |
| 166 | NR3C1_21868756_ChIP-Seq_MCF10A_Human | 0.80991711 |
| 167 | CEBPA_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.80562029 |
| 168 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 0.80001015 |
| 169 | IGF1R_20145208_ChIP-Seq_DFB_Human | 0.79923144 |
| 170 | * CTNNB1_20615089_ChIP-ChIP_FETAL_BRAIN_Human | 0.79822763 |
| 171 | TAF2_19829295_ChIP-Seq_ESCs_Human | 0.79369456 |
| 172 | E2F1_20622854_ChIP-Seq_HELA_Human | 0.79363737 |
| 173 | * FLI1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.78525547 |
| 174 | SOX2_21211035_ChIP-Seq_LN229_Human | 0.78494076 |
| 175 | TFEB_21752829_ChIP-Seq_HELA_Human | 0.78405886 |
| 176 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 0.77425834 |
| 177 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 0.77334760 |
| 178 | RARB_27405468_Chip-Seq_BRAIN_Mouse | 0.77234213 |
| 179 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 0.77043302 |
| 180 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 0.77000625 |
| 181 | RUNX2_22187159_ChIP-Seq_PCA_Human | 0.76965388 |
| 182 | SRY_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 0.76695550 |
| 183 | ERA_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 0.76562148 |
| 184 | AR_21915096_ChIP-Seq_LNCaP-1F5_Human | 0.76465185 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0005464_abnormal_platelet_physiology | 3.70472733 |
| 2 | MP0004043_abnormal_pH_regulation | 3.41882372 |
| 3 | MP0002837_dystrophic_cardiac_calcinosis | 3.36586375 |
| 4 | MP0010386_abnormal_urinary_bladder | 2.98675020 |
| 5 | MP0001835_abnormal_antigen_presentation | 2.97200617 |
| 6 | MP0009780_abnormal_chondrocyte_physiolo | 2.78925038 |
| 7 | MP0003183_abnormal_peptide_metabolism | 2.78754369 |
| 8 | MP0004270_analgesia | 2.65542416 |
| 9 | MP0003195_calcinosis | 2.60344586 |
| 10 | MP0000013_abnormal_adipose_tissue | 2.52803642 |
| 11 | MP0003724_increased_susceptibility_to | 2.24788891 |
| 12 | MP0005379_endocrine/exocrine_gland_phen | 2.19310006 |
| 13 | MP0003172_abnormal_lysosome_physiology | 2.17337269 |
| 14 | MP0002909_abnormal_adrenal_gland | 2.15325526 |
| 15 | MP0005645_abnormal_hypothalamus_physiol | 2.01673325 |
| 16 | MP0003436_decreased_susceptibility_to | 2.00960635 |
| 17 | MP0003075_altered_response_to | 1.97570904 |
| 18 | MP0002734_abnormal_mechanical_nocicepti | 1.95726328 |
| 19 | MP0002148_abnormal_hypersensitivity_rea | 1.95453631 |
| 20 | MP0002638_abnormal_pupillary_reflex | 1.94463280 |
| 21 | MP0006276_abnormal_autonomic_nervous | 1.91448044 |
| 22 | MP0002733_abnormal_thermal_nociception | 1.81669821 |
| 23 | MP0005671_abnormal_response_to | 1.75367385 |
| 24 | MP0002735_abnormal_chemical_nociception | 1.75227985 |
| 25 | MP0000920_abnormal_myelination | 1.71956836 |
| 26 | MP0002272_abnormal_nervous_system | 1.70037742 |
| 27 | MP0010329_abnormal_lipoprotein_level | 1.67060481 |
| 28 | MP0002693_abnormal_pancreas_physiology | 1.67001991 |
| 29 | MP0001905_abnormal_dopamine_level | 1.66200354 |
| 30 | MP0005646_abnormal_pituitary_gland | 1.66173106 |
| 31 | MP0001986_abnormal_taste_sensitivity | 1.65908140 |
| 32 | MP0005000_abnormal_immune_tolerance | 1.64797526 |
| 33 | MP0002876_abnormal_thyroid_physiology | 1.61121477 |
| 34 | MP0001533_abnormal_skeleton_physiology | 1.60651192 |
| 35 | MP0001944_abnormal_pancreas_morphology | 1.59638476 |
| 36 | MP0002139_abnormal_hepatobiliary_system | 1.58801535 |
| 37 | MP0002132_abnormal_respiratory_system | 1.57987951 |
| 38 | MP0009840_abnormal_foam_cell | 1.57541674 |
| 39 | MP0003191_abnormal_cellular_cholesterol | 1.57246891 |
| 40 | MP0006072_abnormal_retinal_apoptosis | 1.56731249 |
| 41 | MP0001970_abnormal_pain_threshold | 1.56444254 |
| 42 | MP0003329_amyloid_beta_deposits | 1.54819199 |
| 43 | MP0003880_abnormal_central_pattern | 1.53359809 |
| 44 | MP0002877_abnormal_melanocyte_morpholog | 1.52743000 |
| 45 | MP0005058_abnormal_lysosome_morphology | 1.51877237 |
| 46 | MP0001958_emphysema | 1.49392106 |
| 47 | MP0009785_altered_susceptibility_to | 1.49144015 |
| 48 | MP0001984_abnormal_olfaction | 1.46167580 |
| 49 | MP0005387_immune_system_phenotype | 1.44948971 |
| 50 | MP0001790_abnormal_immune_system | 1.44948971 |
| 51 | MP0003011_delayed_dark_adaptation | 1.44916693 |
| 52 | MP0004036_abnormal_muscle_relaxation | 1.44034699 |
| 53 | MP0008004_abnormal_stomach_pH | 1.42076416 |
| 54 | MP0000343_altered_response_to | 1.40385351 |
| 55 | MP0001529_abnormal_vocalization | 1.38824010 |
| 56 | MP0003186_abnormal_redox_activity | 1.37967775 |
| 57 | MP0005165_increased_susceptibility_to | 1.35592739 |
| 58 | MP0003806_abnormal_nucleotide_metabolis | 1.35147331 |
| 59 | MP0000465_gastrointestinal_hemorrhage | 1.34677423 |
| 60 | MP0002419_abnormal_innate_immunity | 1.34550756 |
| 61 | MP0000751_myopathy | 1.34170105 |
| 62 | MP0001873_stomach_inflammation | 1.34143894 |
| 63 | MP0006082_CNS_inflammation | 1.31829942 |
| 64 | MP0010155_abnormal_intestine_physiology | 1.31816600 |
| 65 | MP0001502_abnormal_circadian_rhythm | 1.31612470 |
| 66 | MP0002078_abnormal_glucose_homeostasis | 1.30888839 |
| 67 | MP0005535_abnormal_body_temperature | 1.30812329 |
| 68 | MP0005220_abnormal_exocrine_pancreas | 1.30169761 |
| 69 | MP0002064_seizures | 1.29918344 |
| 70 | MP0003879_abnormal_hair_cell | 1.29510704 |
| 71 | MP0001765_abnormal_ion_homeostasis | 1.29172651 |
| 72 | MP0000685_abnormal_immune_system | 1.28895203 |
| 73 | MP0003303_peritoneal_inflammation | 1.28119925 |
| 74 | MP0005365_abnormal_bile_salt | 1.26492977 |
| 75 | MP0003634_abnormal_glial_cell | 1.26469124 |
| 76 | MP0000749_muscle_degeneration | 1.25780833 |
| 77 | MP0003635_abnormal_synaptic_transmissio | 1.24923254 |
| 78 | MP0000003_abnormal_adipose_tissue | 1.23643213 |
| 79 | MP0005085_abnormal_gallbladder_physiolo | 1.23278847 |
| 80 | MP0001968_abnormal_touch/_nociception | 1.23203459 |
| 81 | MP0004145_abnormal_muscle_electrophysio | 1.22136610 |
| 82 | MP0005551_abnormal_eye_electrophysiolog | 1.22119972 |
| 83 | MP0002229_neurodegeneration | 1.19263682 |
| 84 | MP0006054_spinal_hemorrhage | 1.19171294 |
| 85 | MP0005025_abnormal_response_to | 1.18048480 |
| 86 | MP0005166_decreased_susceptibility_to | 1.17135446 |
| 87 | MP0001845_abnormal_inflammatory_respons | 1.16764377 |
| 88 | MP0000230_abnormal_systemic_arterial | 1.15937585 |
| 89 | MP0005084_abnormal_gallbladder_morpholo | 1.15077056 |
| 90 | MP0006036_abnormal_mitochondrial_physio | 1.11749391 |
| 91 | MP0004019_abnormal_vitamin_homeostasis | 1.11259281 |
| 92 | MP0002736_abnormal_nociception_after | 1.09873970 |
| 93 | MP0002723_abnormal_immune_serum | 1.09665738 |
| 94 | MP0005636_abnormal_mineral_homeostasis | 1.09468059 |
| 95 | MP0004924_abnormal_behavior | 1.06897261 |
| 96 | MP0005386_behavior/neurological_phenoty | 1.06897261 |
| 97 | MP0005332_abnormal_amino_acid | 1.05660861 |
| 98 | MP0002572_abnormal_emotion/affect_behav | 1.04643539 |
| 99 | MP0009643_abnormal_urine_homeostasis | 1.04595888 |
| 100 | MP0002163_abnormal_gland_morphology | 1.04540558 |
| 101 | MP0000538_abnormal_urinary_bladder | 1.02935071 |
| 102 | MP0009745_abnormal_behavioral_response | 1.02728109 |
| 103 | MP0002067_abnormal_sensory_capabilities | 1.01969403 |
| 104 | MP0002452_abnormal_antigen_presenting | 1.01783767 |
| 105 | MP0000678_abnormal_parathyroid_gland | 1.01641649 |
| 106 | MP0004510_myositis | 1.00878021 |
| 107 | MP0008469_abnormal_protein_level | 1.00784807 |
| 108 | MP0001486_abnormal_startle_reflex | 1.00589543 |
| 109 | MP0009764_decreased_sensitivity_to | 1.00232942 |
| 110 | MP0001800_abnormal_humoral_immune | 0.99907229 |
| 111 | MP0002420_abnormal_adaptive_immunity | 0.99775407 |
| 112 | MP0002118_abnormal_lipid_homeostasis | 0.99498410 |
| 113 | MP0005075_abnormal_melanosome_morpholog | 0.99016350 |
| 114 | MP0001819_abnormal_immune_cell | 0.98954969 |
| 115 | MP0004142_abnormal_muscle_tone | 0.98255370 |
| 116 | MP0001661_extended_life_span | 0.97951619 |
| 117 | MP0001756_abnormal_urination | 0.96986912 |
| 118 | MP0000747_muscle_weakness | 0.96654069 |
| 119 | MP0004215_abnormal_myocardial_fiber | 0.96543457 |
| 120 | MP0005253_abnormal_eye_physiology | 0.96091958 |
| 121 | MP0004130_abnormal_muscle_cell | 0.96082632 |
| 122 | MP0009333_abnormal_splenocyte_physiolog | 0.95377571 |
| 123 | MP0003868_abnormal_feces_composition | 0.94964080 |
| 124 | MP0008260_abnormal_autophagy | 0.94472250 |
| 125 | MP0001542_abnormal_bone_strength | 0.93918494 |
| 126 | MP0001664_abnormal_digestion | 0.93233475 |
| 127 | MP0008874_decreased_physiological_sensi | 0.93066391 |
| 128 | MP0002295_abnormal_pulmonary_circulatio | 0.92544700 |
| 129 | MP0008872_abnormal_physiological_respon | 0.92267773 |
| 130 | MP0005360_urolithiasis | 0.92090970 |
| 131 | MP0003300_gastrointestinal_ulcer | 0.91903070 |
| 132 | MP0000462_abnormal_digestive_system | 0.91850192 |
| 133 | MP0002184_abnormal_innervation | 0.91257568 |
| 134 | MP0008875_abnormal_xenobiotic_pharmacok | 0.91253212 |
| 135 | MP0003283_abnormal_digestive_organ | 0.90843923 |
| 136 | MP0004147_increased_porphyrin_level | 0.90769005 |
| 137 | MP0002063_abnormal_learning/memory/cond | 0.90764779 |
| 138 | MP0004858_abnormal_nervous_system | 0.90292041 |
| 139 | MP0002405_respiratory_system_inflammati | 0.89773082 |
| 140 | MP0003959_abnormal_lean_body | 0.89768681 |
| 141 | MP0001440_abnormal_grooming_behavior | 0.89388892 |
| 142 | MP0004742_abnormal_vestibular_system | 0.89318645 |
| 143 | MP0002896_abnormal_bone_mineralization | 0.88951773 |
| 144 | MP0001666_abnormal_nutrient_absorption | 0.88528091 |
| 145 | MP0003690_abnormal_glial_cell | 0.88492582 |
| 146 | MP0003953_abnormal_hormone_level | 0.88245805 |
| 147 | MP0005083_abnormal_biliary_tract | 0.87543482 |
| 148 | MP0000955_abnormal_spinal_cord | 0.87526652 |
| 149 | MP0003866_abnormal_defecation | 0.87057553 |
| 150 | MP0005448_abnormal_energy_balance | 0.86198317 |
| 151 | MP0005410_abnormal_fertilization | 0.85786021 |
| 152 | MP0000604_amyloidosis | 0.85226769 |
| 153 | MP0001663_abnormal_digestive_system | 0.84425033 |
| 154 | MP0003633_abnormal_nervous_system | 0.84405948 |
| 155 | MP0001299_abnormal_eye_distance/ | 0.84303689 |
| 156 | MP0009046_muscle_twitch | 0.84279770 |
| 157 | MP0009642_abnormal_blood_homeostasis | 0.83697710 |
| 158 | MP0002972_abnormal_cardiac_muscle | 0.82530886 |
| 159 | MP0004085_abnormal_heartbeat | 0.82482311 |
| 160 | MP0005319_abnormal_enzyme/_coenzyme | 0.82195507 |
| 161 | MP0000015_abnormal_ear_pigmentation | 0.81405117 |
| 162 | MP0002822_catalepsy | 0.81320622 |
| 163 | MP0004782_abnormal_surfactant_physiolog | 0.80746785 |
| 164 | MP0000372_irregular_coat_pigmentation | 0.80548255 |
| 165 | MP0003638_abnormal_response/metabolism_ | 0.79084438 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Petechiae (HP:0000967) | 5.04567549 |
| 2 | Prolonged bleeding time (HP:0003010) | 4.50718977 |
| 3 | Purpura (HP:0000979) | 4.18868266 |
| 4 | Hyperinsulinemic hypoglycemia (HP:0000825) | 3.89957136 |
| 5 | Pheochromocytoma (HP:0002666) | 3.59300470 |
| 6 | Elevated circulating parathyroid hormone (PTH) level (HP:0003165) | 3.58874820 |
| 7 | Hypoglycemic seizures (HP:0002173) | 3.57801728 |
| 8 | Hypoglycemic coma (HP:0001325) | 3.56182681 |
| 9 | Ketoacidosis (HP:0001993) | 3.48929279 |
| 10 | Menorrhagia (HP:0000132) | 3.48501427 |
| 11 | Hypothermia (HP:0002045) | 3.46348995 |
| 12 | Acute necrotizing encephalopathy (HP:0006965) | 3.39506607 |
| 13 | Neuroendocrine neoplasm (HP:0100634) | 3.35746210 |
| 14 | Gingival bleeding (HP:0000225) | 3.34797580 |
| 15 | Symptomatic seizures (HP:0011145) | 3.34178824 |
| 16 | Epistaxis (HP:0000421) | 3.27716438 |
| 17 | Abnormal mitochondria in muscle tissue (HP:0008316) | 3.19913986 |
| 18 | Elevated erythrocyte sedimentation rate (HP:0003565) | 3.19194478 |
| 19 | Neurofibrillary tangles (HP:0002185) | 3.05968463 |
| 20 | Hyperlipoproteinemia (HP:0010980) | 3.05922261 |
| 21 | Acute encephalopathy (HP:0006846) | 2.97523457 |
| 22 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 2.94740782 |
| 23 | Abnormality of liposaccharide metabolism (HP:0010968) | 2.93059749 |
| 24 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 2.93059749 |
| 25 | Abnormality of glycolipid metabolism (HP:0010969) | 2.93059749 |
| 26 | Progressive macrocephaly (HP:0004481) | 2.91838220 |
| 27 | Stomatitis (HP:0010280) | 2.90421545 |
| 28 | Mitochondrial inheritance (HP:0001427) | 2.84163578 |
| 29 | Abnormal platelet volume (HP:0011876) | 2.82957581 |
| 30 | Increased mean platelet volume (HP:0011877) | 2.82173394 |
| 31 | Mitral stenosis (HP:0001718) | 2.80163194 |
| 32 | Abnormality of calcium-phosphate metabolism (HP:0100530) | 2.76455007 |
| 33 | Hepatic necrosis (HP:0002605) | 2.70242660 |
| 34 | Generalized aminoaciduria (HP:0002909) | 2.61762432 |
| 35 | Ketosis (HP:0001946) | 2.59217108 |
| 36 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 2.55391633 |
| 37 | Abnormality of polysaccharide metabolism (HP:0011012) | 2.55391633 |
| 38 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 2.55391633 |
| 39 | Large for gestational age (HP:0001520) | 2.50010639 |
| 40 | Retinal dysplasia (HP:0007973) | 2.46074256 |
| 41 | Tongue fasciculations (HP:0001308) | 2.45008948 |
| 42 | Late onset (HP:0003584) | 2.43838767 |
| 43 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 2.41385653 |
| 44 | Episodic fever (HP:0001954) | 2.41348749 |
| 45 | Hepatocellular necrosis (HP:0001404) | 2.41346506 |
| 46 | Increased cerebral lipofuscin (HP:0011813) | 2.40206545 |
| 47 | Vascular calcification (HP:0004934) | 2.40068611 |
| 48 | Loss of speech (HP:0002371) | 2.35344254 |
| 49 | Cardiovascular calcification (HP:0011915) | 2.31902847 |
| 50 | Prolonged neonatal jaundice (HP:0006579) | 2.31333210 |
| 51 | Decreased circulating renin level (HP:0003351) | 2.30445249 |
| 52 | Muscle fibrillation (HP:0010546) | 2.25230033 |
| 53 | Increased CSF lactate (HP:0002490) | 2.22202442 |
| 54 | Hyperthyroidism (HP:0000836) | 2.20370248 |
| 55 | Cerebral inclusion bodies (HP:0100314) | 2.20166110 |
| 56 | Action tremor (HP:0002345) | 2.17471230 |
| 57 | Renal Fanconi syndrome (HP:0001994) | 2.17091872 |
| 58 | Protuberant abdomen (HP:0001538) | 2.16709740 |
| 59 | Hyperglycemia (HP:0003074) | 2.16007938 |
| 60 | Degeneration of the lateral corticospinal tracts (HP:0002314) | 2.15376442 |
| 61 | Atrophy/Degeneration involving the corticospinal tracts (HP:0007372) | 2.15376442 |
| 62 | Epiphyseal dysplasia (HP:0002656) | 2.13854649 |
| 63 | Cerebral hemorrhage (HP:0001342) | 2.13627185 |
| 64 | Atonic seizures (HP:0010819) | 2.13273300 |
| 65 | Methylmalonic acidemia (HP:0002912) | 2.12309360 |
| 66 | Cerebral edema (HP:0002181) | 2.10358698 |
| 67 | Hypokalemia (HP:0002900) | 2.09966362 |
| 68 | Systemic lupus erythematosus (HP:0002725) | 2.09408855 |
| 69 | Growth hormone excess (HP:0000845) | 2.08996365 |
| 70 | Lipid accumulation in hepatocytes (HP:0006561) | 2.08122207 |
| 71 | Testicular neoplasm (HP:0010788) | 2.08071344 |
| 72 | Joint swelling (HP:0001386) | 2.07223900 |
| 73 | Palpitations (HP:0001962) | 2.06108746 |
| 74 | Impaired platelet aggregation (HP:0003540) | 2.06042591 |
| 75 | Abnormal platelet function (HP:0011869) | 2.06042591 |
| 76 | Hepatosplenomegaly (HP:0001433) | 2.05446097 |
| 77 | Abnormal pupillary function (HP:0007686) | 2.01749707 |
| 78 | J-shaped sella turcica (HP:0002680) | 2.01624510 |
| 79 | Myoglobinuria (HP:0002913) | 2.01281322 |
| 80 | Abnormality of macrophages (HP:0004311) | 2.01157715 |
| 81 | Increased muscle lipid content (HP:0009058) | 2.00513344 |
| 82 | Disproportionate short-trunk short stature (HP:0003521) | 1.99996970 |
| 83 | Vacuolated lymphocytes (HP:0001922) | 1.99298926 |
| 84 | Xanthomatosis (HP:0000991) | 1.98700007 |
| 85 | Hypokalemic alkalosis (HP:0001949) | 1.98243376 |
| 86 | Abnormality of the pancreatic islet cells (HP:0006476) | 1.97950947 |
| 87 | Abnormality of endocrine pancreas physiology (HP:0012093) | 1.97950947 |
| 88 | Methylmalonic aciduria (HP:0012120) | 1.97943918 |
| 89 | Supranuclear gaze palsy (HP:0000605) | 1.97740003 |
| 90 | Abnormal tarsal ossification (HP:0008369) | 1.97164530 |
| 91 | Abnormal pancreas size (HP:0012094) | 1.96643779 |
| 92 | Hyperactive renin-angiotensin system (HP:0000841) | 1.94460527 |
| 93 | Abnormality of long-chain fatty-acid metabolism (HP:0010964) | 1.94257750 |
| 94 | Menstrual irregularities (HP:0000858) | 1.93882210 |
| 95 | Hypotension (HP:0002615) | 1.92803424 |
| 96 | Conjugated hyperbilirubinemia (HP:0002908) | 1.92203806 |
| 97 | Abnormality of iron homeostasis (HP:0011031) | 1.91875023 |
| 98 | Abnormality of the intrinsic pathway (HP:0010989) | 1.91407054 |
| 99 | Postural tremor (HP:0002174) | 1.91114988 |
| 100 | Agitation (HP:0000713) | 1.89845065 |
| 101 | Increased intramyocellular lipid droplets (HP:0012240) | 1.89430625 |
| 102 | EEG with generalized epileptiform discharges (HP:0011198) | 1.89322166 |
| 103 | Glycosuria (HP:0003076) | 1.88816298 |
| 104 | Abnormality of urine glucose concentration (HP:0011016) | 1.88816298 |
| 105 | Irregular vertebral endplates (HP:0003301) | 1.88579261 |
| 106 | Abnormality of renin-angiotensin system (HP:0000847) | 1.88382131 |
| 107 | Anxiety (HP:0000739) | 1.87697710 |
| 108 | Exercise-induced myalgia (HP:0003738) | 1.87573797 |
| 109 | Dysostosis multiplex (HP:0000943) | 1.86906382 |
| 110 | Central scotoma (HP:0000603) | 1.86356361 |
| 111 | Increased IgM level (HP:0003496) | 1.85616594 |
| 112 | Optic disc pallor (HP:0000543) | 1.85022967 |
| 113 | Abnormal respiratory epithelium morphology (HP:0012253) | 1.84701406 |
| 114 | Abnormal respiratory motile cilium morphology (HP:0005938) | 1.84701406 |
| 115 | Epileptiform EEG discharges (HP:0011182) | 1.84196940 |
| 116 | Increased circulating renin level (HP:0000848) | 1.82662139 |
| 117 | Type II lissencephaly (HP:0007260) | 1.82621782 |
| 118 | Progressive neurologic deterioration (HP:0002344) | 1.82082527 |
| 119 | Hyperparathyroidism (HP:0000843) | 1.81730609 |
| 120 | Increased hepatocellular lipid droplets (HP:0006565) | 1.80915989 |
| 121 | Abnormality of fatty-acid metabolism (HP:0004359) | 1.80797339 |
| 122 | Insulin-resistant diabetes mellitus (HP:0000831) | 1.80558387 |
| 123 | 3-Methylglutaconic aciduria (HP:0003535) | 1.80262675 |
| 124 | Hypsarrhythmia (HP:0002521) | 1.80122683 |
| 125 | Abnormality of transition element cation homeostasis (HP:0011030) | 1.79816066 |
| 126 | Increased CSF protein (HP:0002922) | 1.79721935 |
| 127 | Abnormality of the vertebral endplates (HP:0005106) | 1.79253609 |
| 128 | Pancreatic islet-cell hyperplasia (HP:0004510) | 1.78652086 |
| 129 | Albinism (HP:0001022) | 1.78274016 |
| 130 | Lactic acidosis (HP:0003128) | 1.77935042 |
| 131 | Mucopolysacchariduria (HP:0008155) | 1.77690507 |
| 132 | Urinary glycosaminoglycan excretion (HP:0003541) | 1.77690507 |
| 133 | Limb dystonia (HP:0002451) | 1.77504175 |
| 134 | Increased serum ferritin (HP:0003281) | 1.77452882 |
| 135 | Hypomagnesemia (HP:0002917) | 1.77161933 |
| 136 | Cutaneous melanoma (HP:0012056) | 1.76801472 |
| 137 | Leukodystrophy (HP:0002415) | 1.76108167 |
| 138 | Vertebral compression fractures (HP:0002953) | 1.75970911 |
| 139 | Abnormality of magnesium homeostasis (HP:0004921) | 1.75184102 |
| 140 | Glucose intolerance (HP:0000833) | 1.74971563 |
| 141 | Hyperkalemia (HP:0002153) | 1.74763910 |
| 142 | Respiratory failure (HP:0002878) | 1.74695339 |
| 143 | Abnormal protein glycosylation (HP:0012346) | 1.73962946 |
| 144 | Abnormal glycosylation (HP:0012345) | 1.73962946 |
| 145 | Abnormal isoelectric focusing of serum transferrin (HP:0003160) | 1.73962946 |
| 146 | Abnormal protein N-linked glycosylation (HP:0012347) | 1.73962946 |
| 147 | Hyperphosphaturia (HP:0003109) | 1.72280484 |
| 148 | Congenital sensorineural hearing impairment (HP:0008527) | 1.72097596 |
| 149 | Type I transferrin isoform profile (HP:0003642) | 1.71561072 |
| 150 | Dysautonomia (HP:0002459) | 1.71018442 |
| 151 | Dicarboxylic aciduria (HP:0003215) | 1.70842891 |
| 152 | Abnormality of dicarboxylic acid metabolism (HP:0010995) | 1.70842891 |
| 153 | Oligomenorrhea (HP:0000876) | 1.70282372 |
| 154 | Resting tremor (HP:0002322) | 1.70232939 |
| 155 | Hypergammaglobulinemia (HP:0010702) | 1.70107833 |
| 156 | Abnormality of proline metabolism (HP:0010907) | 1.70060034 |
| 157 | Hydroxyprolinuria (HP:0003080) | 1.70060034 |
| 158 | Autoamputation (HP:0001218) | 1.68888321 |
| 159 | Basal ganglia calcification (HP:0002135) | 1.68610039 |
| 160 | Arthropathy (HP:0003040) | 1.68598559 |
| 161 | Myositis (HP:0100614) | 1.68189428 |
| 162 | Joint hemorrhage (HP:0005261) | 1.64814223 |
| 163 | Polyphagia (HP:0002591) | 1.64199919 |
| 164 | Bruising susceptibility (HP:0000978) | 1.63429455 |
| 165 | Bone cyst (HP:0012062) | 1.62653598 |
| 166 | Cerebral palsy (HP:0100021) | 1.61989151 |
| 167 | Cardiomegaly (HP:0001640) | 1.60146171 |
| 168 | Pulmonary infiltrates (HP:0002113) | 1.57563399 |
| 169 | Intracellular accumulation of autofluorescent lipopigment storage material (HP:0003204) | 1.57080665 |
| 170 | Nuclear cataract (HP:0100018) | 1.56526624 |
| 171 | Joint stiffness (HP:0001387) | 1.55632206 |
| 172 | Abnormality of glutamine family amino acid metabolism (HP:0010902) | 1.55621881 |
| 173 | Amyloidosis (HP:0011034) | 1.54400980 |
| 174 | Abnormal ciliary motility (HP:0012262) | 1.53802541 |
| 175 | Rhinitis (HP:0012384) | 1.50740716 |
| 176 | Abnormal activity of mitochondrial respiratory chain (HP:0011922) | 1.49809719 |
| 177 | Decreased activity of mitochondrial respiratory chain (HP:0008972) | 1.49809719 |
| 178 | Acute hepatic failure (HP:0006554) | 1.47419725 |
| 179 | Obstructive lung disease (HP:0006536) | 1.46584713 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | INSRR | 3.69447537 |
| 2 | WNK4 | 3.25348013 |
| 3 | STK39 | 3.12096802 |
| 4 | MAPK15 | 2.86582196 |
| 5 | NTRK1 | 2.66454110 |
| 6 | RIPK4 | 2.45120446 |
| 7 | FES | 2.34325366 |
| 8 | TNK2 | 2.14991332 |
| 9 | TRIM28 | 2.10612956 |
| 10 | OXSR1 | 2.09482495 |
| 11 | MAP3K2 | 2.01215266 |
| 12 | TXK | 1.85155468 |
| 13 | BCR | 1.79899904 |
| 14 | BCKDK | 1.79886600 |
| 15 | PIK3CG | 1.78706961 |
| 16 | PHKG1 | 1.75340686 |
| 17 | PHKG2 | 1.75340686 |
| 18 | ZAP70 | 1.75180060 |
| 19 | CASK | 1.70061325 |
| 20 | LIMK1 | 1.57471290 |
| 21 | EPHB1 | 1.56978697 |
| 22 | IRAK1 | 1.53812441 |
| 23 | MAP4K1 | 1.53753181 |
| 24 | ARAF | 1.52757148 |
| 25 | MET | 1.52603675 |
| 26 | GRK6 | 1.51231034 |
| 27 | MAPKAPK3 | 1.47613775 |
| 28 | UHMK1 | 1.44284059 |
| 29 | MAP3K11 | 1.41045973 |
| 30 | NME1 | 1.37712473 |
| 31 | FLT3 | 1.36954161 |
| 32 | PRKD3 | 1.36239149 |
| 33 | PIM2 | 1.34570583 |
| 34 | WNK3 | 1.33769762 |
| 35 | CAMK2D | 1.32901623 |
| 36 | MAPKAPK5 | 1.30639188 |
| 37 | PAK3 | 1.29590275 |
| 38 | MST4 | 1.28429615 |
| 39 | MYLK | 1.27923011 |
| 40 | OBSCN | 1.27339880 |
| 41 | SGK223 | 1.26930206 |
| 42 | SGK494 | 1.26930206 |
| 43 | IRAK2 | 1.24527657 |
| 44 | FRK | 1.23924869 |
| 45 | HIPK2 | 1.23787262 |
| 46 | TBK1 | 1.19344656 |
| 47 | NTRK3 | 1.18978774 |
| 48 | EPHA3 | 1.16221813 |
| 49 | IRAK3 | 1.16096958 |
| 50 | GRK5 | 1.15805343 |
| 51 | WNK1 | 1.15657230 |
| 52 | KIT | 1.13037661 |
| 53 | EIF2AK1 | 1.12560088 |
| 54 | IKBKB | 1.12314961 |
| 55 | BLK | 1.12081837 |
| 56 | BMPR1B | 1.12042282 |
| 57 | PRKCE | 1.11207995 |
| 58 | CAMK2B | 1.10998864 |
| 59 | PRKD2 | 1.10361742 |
| 60 | DAPK1 | 1.09447103 |
| 61 | SYK | 1.08840789 |
| 62 | TYK2 | 1.08584646 |
| 63 | JAK1 | 1.08579169 |
| 64 | MAP2K6 | 1.08174136 |
| 65 | SIK3 | 1.08052989 |
| 66 | TEC | 1.07661678 |
| 67 | PRPF4B | 1.07594404 |
| 68 | TIE1 | 1.06545319 |
| 69 | AKT3 | 1.04521038 |
| 70 | MAP2K3 | 1.03271910 |
| 71 | BTK | 1.01933305 |
| 72 | EIF2AK3 | 1.01177267 |
| 73 | MAP2K7 | 1.00741004 |
| 74 | DAPK3 | 0.99725624 |
| 75 | CSF1R | 0.97666907 |
| 76 | ILK | 0.96082924 |
| 77 | LMTK2 | 0.94743738 |
| 78 | MUSK | 0.93903092 |
| 79 | DAPK2 | 0.93855467 |
| 80 | TAOK3 | 0.93199063 |
| 81 | CAMKK2 | 0.92539627 |
| 82 | CAMK2G | 0.88778103 |
| 83 | PASK | 0.86778117 |
| 84 | PINK1 | 0.86735824 |
| 85 | TNIK | 0.84702837 |
| 86 | CAMK2A | 0.84525071 |
| 87 | BMX | 0.83470046 |
| 88 | MAP3K1 | 0.82970850 |
| 89 | KSR2 | 0.82945788 |
| 90 | NEK6 | 0.82671312 |
| 91 | BMPR2 | 0.80818783 |
| 92 | STK38 | 0.80505258 |
| 93 | TLK1 | 0.80015400 |
| 94 | CSNK1G3 | 0.79198915 |
| 95 | CDK19 | 0.76355399 |
| 96 | ACVR1B | 0.76268745 |
| 97 | HCK | 0.75768955 |
| 98 | MAP3K4 | 0.72671411 |
| 99 | MINK1 | 0.70514521 |
| 100 | PDK1 | 0.70223684 |
| 101 | RET | 0.70180750 |
| 102 | PKN1 | 0.69514769 |
| 103 | MAPK13 | 0.68546191 |
| 104 | FER | 0.68524719 |
| 105 | TAOK2 | 0.67952551 |
| 106 | CDK5 | 0.67509049 |
| 107 | MAP2K4 | 0.66871332 |
| 108 | ADRBK1 | 0.66612995 |
| 109 | MAP3K5 | 0.65954157 |
| 110 | TRPM7 | 0.65482592 |
| 111 | LYN | 0.64388666 |
| 112 | CSNK1G2 | 0.64362149 |
| 113 | TRIB3 | 0.64265694 |
| 114 | TAOK1 | 0.62656532 |
| 115 | STK16 | 0.62358754 |
| 116 | GRK7 | 0.61478166 |
| 117 | MAPK12 | 0.60564949 |
| 118 | MAP2K2 | 0.59161654 |
| 119 | PRKCH | 0.58774989 |
| 120 | ABL2 | 0.58447126 |
| 121 | MAP3K12 | 0.58048759 |
| 122 | PDK2 | 0.57659342 |
| 123 | MARK1 | 0.57156675 |
| 124 | BRAF | 0.57059303 |
| 125 | PDK3 | 0.55129674 |
| 126 | PDK4 | 0.55129674 |
| 127 | MAP2K1 | 0.55038003 |
| 128 | DYRK2 | 0.53326264 |
| 129 | ERN1 | 0.53038874 |
| 130 | PRKG2 | 0.53021131 |
| 131 | PTK2 | 0.52917057 |
| 132 | ERBB3 | 0.52100893 |
| 133 | ADRBK2 | 0.51957771 |
| 134 | ROCK2 | 0.51008853 |
| 135 | JAK2 | 0.50419432 |
| 136 | PRKD1 | 0.50212811 |
| 137 | RPS6KA2 | 0.49420889 |
| 138 | TESK1 | 0.49418201 |
| 139 | CSK | 0.49359865 |
| 140 | TESK2 | 0.49163404 |
| 141 | PRKACA | 0.48693982 |
| 142 | CSNK1G1 | 0.48434810 |
| 143 | EPHA4 | 0.48081023 |
| 144 | PTK2B | 0.47754381 |
| 145 | MAP4K2 | 0.47411288 |
| 146 | MAP3K3 | 0.46773530 |
| 147 | PDPK1 | 0.46127599 |
| 148 | SGK2 | 0.45959977 |
| 149 | MAP3K6 | 0.45686274 |
| 150 | GRK1 | 0.45283569 |
| 151 | PRKCQ | 0.44486791 |
| 152 | JAK3 | 0.44399150 |
| 153 | ITK | 0.43505023 |
| 154 | PKN2 | 0.43487602 |
| 155 | LRRK2 | 0.43436283 |
| 156 | CAMKK1 | 0.42700278 |
| 157 | LCK | 0.41208370 |
| 158 | SCYL2 | 0.40978817 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Protein export_Homo sapiens_hsa03060 | 3.96554055 |
| 2 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 3.77498818 |
| 3 | Sulfur metabolism_Homo sapiens_hsa00920 | 3.32629973 |
| 4 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 2.80542063 |
| 5 | Fatty acid elongation_Homo sapiens_hsa00062 | 2.42787511 |
| 6 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 2.28649074 |
| 7 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 2.15308178 |
| 8 | Parkinsons disease_Homo sapiens_hsa05012 | 2.14125401 |
| 9 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 2.10518652 |
| 10 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 2.01732681 |
| 11 | Steroid biosynthesis_Homo sapiens_hsa00100 | 2.00911708 |
| 12 | Alzheimers disease_Homo sapiens_hsa05010 | 1.83282041 |
| 13 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 1.78926825 |
| 14 | Insulin secretion_Homo sapiens_hsa04911 | 1.75118403 |
| 15 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 1.75116824 |
| 16 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 1.71585111 |
| 17 | Butanoate metabolism_Homo sapiens_hsa00650 | 1.67929858 |
| 18 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 1.60153103 |
| 19 | Propanoate metabolism_Homo sapiens_hsa00640 | 1.56138637 |
| 20 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 1.55639045 |
| 21 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 1.50302655 |
| 22 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 1.45547841 |
| 23 | Allograft rejection_Homo sapiens_hsa05330 | 1.42562949 |
| 24 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 1.42151816 |
| 25 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | 1.42101991 |
| 26 | Platelet activation_Homo sapiens_hsa04611 | 1.40822901 |
| 27 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 1.39496476 |
| 28 | Histidine metabolism_Homo sapiens_hsa00340 | 1.37505938 |
| 29 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 1.33403605 |
| 30 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 1.31823485 |
| 31 | Graft-versus-host disease_Homo sapiens_hsa05332 | 1.30038384 |
| 32 | Fatty acid metabolism_Homo sapiens_hsa01212 | 1.28809831 |
| 33 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 1.28607528 |
| 34 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 1.24585235 |
| 35 | Fatty acid degradation_Homo sapiens_hsa00071 | 1.23521183 |
| 36 | Cocaine addiction_Homo sapiens_hsa05030 | 1.22928584 |
| 37 | Pyruvate metabolism_Homo sapiens_hsa00620 | 1.20791348 |
| 38 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 1.13845850 |
| 39 | Huntingtons disease_Homo sapiens_hsa05016 | 1.13750185 |
| 40 | Regulation of autophagy_Homo sapiens_hsa04140 | 1.13367922 |
| 41 | Tyrosine metabolism_Homo sapiens_hsa00350 | 1.10937356 |
| 42 | Serotonergic synapse_Homo sapiens_hsa04726 | 1.09143405 |
| 43 | Glutathione metabolism_Homo sapiens_hsa00480 | 1.06587077 |
| 44 | Tryptophan metabolism_Homo sapiens_hsa00380 | 1.05454881 |
| 45 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 1.04611667 |
| 46 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 1.04482865 |
| 47 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 1.03720348 |
| 48 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 1.02947339 |
| 49 | Peroxisome_Homo sapiens_hsa04146 | 1.02921458 |
| 50 | Ether lipid metabolism_Homo sapiens_hsa00565 | 1.01288943 |
| 51 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 1.01103376 |
| 52 | Lysosome_Homo sapiens_hsa04142 | 0.98243301 |
| 53 | GABAergic synapse_Homo sapiens_hsa04727 | 0.96808275 |
| 54 | Taste transduction_Homo sapiens_hsa04742 | 0.95132340 |
| 55 | Other glycan degradation_Homo sapiens_hsa00511 | 0.94548575 |
| 56 | Folate biosynthesis_Homo sapiens_hsa00790 | 0.94546421 |
| 57 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 0.94222116 |
| 58 | Asthma_Homo sapiens_hsa05310 | 0.94034486 |
| 59 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 0.91140040 |
| 60 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 0.90720205 |
| 61 | Renin-angiotensin system_Homo sapiens_hsa04614 | 0.90025899 |
| 62 | Dopaminergic synapse_Homo sapiens_hsa04728 | 0.88986602 |
| 63 | Amphetamine addiction_Homo sapiens_hsa05031 | 0.88111003 |
| 64 | Circadian entrainment_Homo sapiens_hsa04713 | 0.86513616 |
| 65 | Pancreatic secretion_Homo sapiens_hsa04972 | 0.79415440 |
| 66 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 0.79133552 |
| 67 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 0.78199410 |
| 68 | Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | 0.77484863 |
| 69 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.76556179 |
| 70 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 0.74739508 |
| 71 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.74483078 |
| 72 | Cholinergic synapse_Homo sapiens_hsa04725 | 0.74344414 |
| 73 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 0.73838478 |
| 74 | Leishmaniasis_Homo sapiens_hsa05140 | 0.71214545 |
| 75 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 0.69421795 |
| 76 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.68631671 |
| 77 | Phototransduction_Homo sapiens_hsa04744 | 0.67032283 |
| 78 | Morphine addiction_Homo sapiens_hsa05032 | 0.66774684 |
| 79 | Olfactory transduction_Homo sapiens_hsa04740 | 0.65784181 |
| 80 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 0.65254820 |
| 81 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 0.65024287 |
| 82 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.64372355 |
| 83 | Malaria_Homo sapiens_hsa05144 | 0.63072639 |
| 84 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.62329664 |
| 85 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.62190344 |
| 86 | Phagosome_Homo sapiens_hsa04145 | 0.61204561 |
| 87 | Tuberculosis_Homo sapiens_hsa05152 | 0.61087217 |
| 88 | Endocytosis_Homo sapiens_hsa04144 | 0.61075562 |
| 89 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 0.60269165 |
| 90 | Osteoclast differentiation_Homo sapiens_hsa04380 | 0.59925423 |
| 91 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | 0.59242643 |
| 92 | Retinol metabolism_Homo sapiens_hsa00830 | 0.59059239 |
| 93 | Antigen processing and presentation_Homo sapiens_hsa04612 | 0.58879188 |
| 94 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.57305573 |
| 95 | Pertussis_Homo sapiens_hsa05133 | 0.56402744 |
| 96 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 0.56177556 |
| 97 | Renin secretion_Homo sapiens_hsa04924 | 0.55999020 |
| 98 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.55525555 |
| 99 | Mineral absorption_Homo sapiens_hsa04978 | 0.54442061 |
| 100 | Metabolic pathways_Homo sapiens_hsa01100 | 0.53686780 |
| 101 | Glutamatergic synapse_Homo sapiens_hsa04724 | 0.52734835 |
| 102 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.52351951 |
| 103 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 0.51777552 |
| 104 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 0.51113039 |
| 105 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.48229291 |
| 106 | Proteasome_Homo sapiens_hsa03050 | 0.48096712 |
| 107 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 0.47783003 |
| 108 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.46426068 |
| 109 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.46195839 |
| 110 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 0.45888101 |
| 111 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 0.44966896 |
| 112 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 0.44570897 |
| 113 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 0.44479411 |
| 114 | Salmonella infection_Homo sapiens_hsa05132 | 0.44230357 |
| 115 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 0.43874286 |
| 116 | PPAR signaling pathway_Homo sapiens_hsa03320 | 0.43038423 |
| 117 | ABC transporters_Homo sapiens_hsa02010 | 0.42622141 |
| 118 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.42490473 |
| 119 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.42168197 |
| 120 | Circadian rhythm_Homo sapiens_hsa04710 | 0.41161658 |
| 121 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.40742970 |
| 122 | Protein digestion and absorption_Homo sapiens_hsa04974 | 0.40368306 |
| 123 | Nitrogen metabolism_Homo sapiens_hsa00910 | 0.40110234 |
| 124 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.38909211 |
| 125 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 0.38731216 |
| 126 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.38077587 |
| 127 | Galactose metabolism_Homo sapiens_hsa00052 | 0.37583391 |
| 128 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 0.37540205 |
| 129 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 0.37407002 |
| 130 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 0.36979841 |
| 131 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.36854752 |
| 132 | Salivary secretion_Homo sapiens_hsa04970 | 0.36763671 |
| 133 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.36671663 |
| 134 | Fat digestion and absorption_Homo sapiens_hsa04975 | 0.36460406 |
| 135 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.35935292 |
| 136 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.35662218 |
| 137 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 0.34780111 |
| 138 | Gastric acid secretion_Homo sapiens_hsa04971 | 0.34697159 |
| 139 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.34391887 |
| 140 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 0.34378343 |
| 141 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 0.33819864 |
| 142 | Long-term potentiation_Homo sapiens_hsa04720 | 0.32650369 |

